What missed opportunities will incumbents one day wish they had taken advantage of? Adopting a new mentality will disrupt the industry from the inside out.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures

CVS, Aetna, and UnitedHealthcare are just a few leading names that may forever change healthcare delivery. Should traditional health systems cling to the status quo or go with the flow?

Partner, Health and Life Sciences, Oliver Wyman

What some of healthcare’s most influential voices had to say about the past, present, and future of the industry on the Summit's final day.

Insights in your inbox

Subscribe

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health and Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights from the Summit’s Executive Sessions where speakers dove deep into topics like consumerism, pharma, the future of trading flow, and artificial intelligence.

How a “sticky” consumer experience could help control the drain of high-cost chronic disease drugs.

Partner, Health and Life Sciences, Oliver Wyman

Many healthcare organizations are unsure about how to align their measurement efforts with patients’ priorities. Here's how.

Senior Researcher, American Institutes for Research

Our research uncovers what US consumers want from their healthcare experience. It turns out some consumers are more than happy to "buy up" for health offerings that meet their unique needs.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Insights in your inbox

Subscribe
Load More